Research programme: factor Xa inhibitors - Deinove
Alternative Names: MCM-09; MCM-16; MCM-17; Orally available antithrombotics - DeinoveLatest Information Update: 07 Feb 2019
At a glance
- Originator Morphochem AG
- Class Small molecules
- Mechanism of Action Angiogenesis inhibitors; Factor Xa inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Arterial thrombosis; Cancer metastases; Venous thrombosis
Most Recent Events
- 28 Jul 2010 Discontinued - Preclinical for Arterial thrombosis in Germany (PO)
- 28 Jul 2010 Discontinued - Preclinical for Arterial thrombosis in Germany (unspecified route)
- 28 Jul 2010 Discontinued - Preclinical for Cancer metastases in Germany (unspecified route)